Anpario (LON:ANP) Reaches New 1-Year High – Still a Buy?

Shares of Anpario plc (LON:ANP) hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 580 and last traded at GBX 570, with a volume of 18217 shares. The stock had previously closed at GBX 570.

Analyst Upgrades and Downgrades

ANP has been the subject of several recent analyst reports. Canaccord Genuity Group raised their target price on Anpario from GBX 550 to GBX 570 and gave the company a “buy” rating in a research note on Thursday, January 22nd. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a report on Monday, January 19th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 570.

Anpario Trading Up 2.6%

The company has a market cap of £97.35 million, a price-to-earnings ratio of 19.33 and a beta of 0.58. The firm has a 50-day moving average price of GBX 505.32 and a 200 day moving average price of GBX 477.41. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.